Daniel Mascarenhas MD in Phillipsburg, New Jersey

Medical School: Sorry, his university is not listed
Graduation Year: 1979
The Primary Medical Specialty for Daniel Mascarenhas MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 45
PAC (PECOS ID)#: 3476544487
NPI #: 1568558906
NPI Created On: 10/05/2006
NPI Last Updated Listed as: 05/13/2008
Primary Taxonomy Code: 207RC0000X
License Number:
MD051153L
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• AmeriHealth New Jersey
• Blue Cross Blue Shield
• Capital Advantage Assurance Company
• Highmark Health Insurance Company
• Humana
• Highmark Inc.
• Oscar Garden State Insurance Corporation
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Hindi,Portuguese,Spanish, Hindi.

Services and Procedures include:

1. Insertion of heart rhythm monitor under skin
2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
3. Routine ekg using at least 12 leads including interpretation and report
4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
5. Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days
6. Heart rhythm tracing, computer analysis, physician prescribed transmission of patient-triggered events greater than 24-hour ekg up to 30 days
7. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
8. Remote evaluations of defibrillator up to 90 days with analysis, review and report
9. Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
10. Remote evaluations of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report, up to 30 days
11. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
12. New patient office or other outpatient visit, typically 30 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Established patient office or other outpatient, visit typically 40 minutes
16. Technetium tc-99m sestamibi, diagnostic, per study dose
17. Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec
18. Injection, regadenoson, 0.1 mg